Cipla
Search results
Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries. Subscribe on YouTube. Sun Pharma Story.
Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe.
Sun Pharmaceutical Industries Ltd (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active...
1 day ago · Sun Pharma share price was Rs 1,494.50 as on 24 Jun, 2024, 03:58 PM IST. Sun Pharma share price was up by 1.86% based on previous share price of Rs 1,471. Sun Pharma share price trend: Last 1 Month: Sun Pharma share price moved up by 0.52%; Last 3 Months: Sun Pharma share price moved down by 7.11%; Last 12 Months: Sun Pharma share price moved ...
5 days ago · Sun Pharmaceutical Industries Limited Stock Price Today, Live NSE Share Price: Get the latest Sun Pharmaceutical Industries Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Jan 31, 2024 · India's largest drugmaker Sun Pharmaceutical Industries reported third-quarter profit above estimates on Wednesday, driven by strong sales in the key domestic and U.S. markets.
1 day ago · Sun Pharma has been the majority shareholder of Taro since 2010. The company had first announced to take over the US generics major 17 years ago, in 2007, for $454 million, but the Taro ...
2 days ago · Sun Pharma Industries on Monday said it has completed the merger of Taro Pharmaceutical Industries with itself in a deal valued at $347.73 million. As part of the merger, Sun Pharma has ...
